Napredna pretraga

Pregled bibliografske jedinice broj: 667306

Draft genome sequence of Streptomyces rapamycinicus NRRL 5491, the producer of the immunosuppressant rapamycin


Baranasic, Damir; Gacesa, Ranko; Starcevic, Antonio; Zucko, Jurica; Blažič, Marko; Horvat, Marinka; Gjuračić, Krešimir; Fujs, Štefan; Hranueli, Daslav; Kosec, Gregor et al.
Draft genome sequence of Streptomyces rapamycinicus NRRL 5491, the producer of the immunosuppressant rapamycin // Genome Announcements, 1 (2013), 4; e00581-13 (Article number) doi::10.1128/genomeA.00581-13 (međunarodna recenzija, članak, znanstveni)


Naslov
Draft genome sequence of Streptomyces rapamycinicus NRRL 5491, the producer of the immunosuppressant rapamycin

Autori
Baranasic, Damir ; Gacesa, Ranko ; Starcevic, Antonio ; Zucko, Jurica ; Blažič, Marko ; Horvat, Marinka ; Gjuračić, Krešimir ; Fujs, Štefan ; Hranueli, Daslav ; Kosec, Gregor ; Cullum, John ; Petković, Hrvoje

Izvornik
Genome Announcements (2169-8287) 1 (2013), 4; E00581-13 (Article number)

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Genome sequence; Streptomyces rapamycinicus; rapamycin; secondary metabolite biosynthesis clusters

Sažetak
Streptomyces rapamycinicus strain NRRL 5491 produces the important drug rapamycin. It has a large genome of 12.7 Mb, of which over 3 Mb consists of 48 secondary metabolite biosynthesis clusters.

Izvorni jezik
Engleski

Znanstvena područja
Biotehnologija



POVEZANOST RADA


Projekt / tema
058-0000000-3475 - Generiranje potencijalnih lijekova u uvjetima in silico (Daslav Hranueli, )

Ustanove
Prehrambeno-biotehnološki fakultet, Zagreb

Časopis indeksira:


  • Scopus


Citati